Cargando…

Results of Late Gadolinium Enhancement in Children Affected by Dilated Cardiomyopathy

BACKGROUND: Little is known about the clinical value of late gadolinium enhancement (LGE), in children affected by dilated cardiomyopathy (DCM). MATERIALS AND METHODS: We retrospectively evaluated 15 patients (8 ± 6 years, 6 males) with diagnosis of DCM who underwent cardiac magnetic resonance since...

Descripción completa

Detalles Bibliográficos
Autores principales:	Muscogiuri, Giuseppe, Ciliberti, Paolo, Mastrodicasa, Domenico, Chinali, Marcello, Rinelli, Gabriele, Santangelo, Teresa Pia, Napolitano, Carmela, Leonardi, Benedetta, Secinaro, Aurelio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Pediatrics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5292614/ https://www.ncbi.nlm.nih.gov/pubmed/28220144 http://dx.doi.org/10.3389/fped.2017.00013

Ejemplares similares

Correlation between RVOT sizing and RV function and volumes in patients with repaired tetralogy of Fallot undergoing routine CMR follow-up: is there a better candidate for percutaneous pulmonary valve implantation?
por: Secinaro, Aurelio, et al.
Publicado: (2015)

Cardiac Imaging in Patients After Fontan Palliation: Which Test and When?
por: Ciliberti, Paolo, et al.
Publicado: (2022)

Echocardiographic two-dimensional speckle tracking identifies acute regional myocardial edema and sub-acute fibrosis in pediatric focal myocarditis with normal ejection fraction: comparison with cardiac magnetic resonance
por: Chinali, Marcello, et al.
Publicado: (2020)

Quantitative Assessment of Parenchymal Involvement Using 3D Lung Model in Adolescent With Covid-19 Interstitial Pneumonia
por: Borro, Luca, et al.
Publicado: (2020)

The impact of age on right ventricular morphology and function late after repair of Tetralogy of Fallot: a cardiac magnetic resonance study
por: Leonardi, Benedetta, et al.
Publicado: (2014)

Intra-cardiac distribution of late gadolinium enhancement in cardiac sarcoidosis and dilated cardiomyopathy
por: Sano, Makoto, et al.
Publicado: (2016)

Outcome in Dilated Cardiomyopathy Related to the Extent, Location, and Pattern of Late Gadolinium Enhancement
por: Halliday, Brian P., et al.
Publicado: (2019)

RE: Relation of Late Gadolinium Enhancement to Increased Ventricular Wall Stress in Dilated Cardiomyopathy
por: Alter, Peter
Publicado: (2016)

Electrocardiographic characteristics associated with late gadolinium enhancement and prognostic value in patients with dilated cardiomyopathy
por: Chayanopparat, Punyanuch, et al.
Publicado: (2023)

Association between late gadolinium enhancement and outcome in dilated cardiomyopathy: A meta-analysis
por: Feng, Xin-Yi, et al.
Publicado: (2023)

Late gadolinium enhancement score (LGE-Score) for prediction of extensive late gadolinium enhancement in hypertrophic cardiomyopathy
por: Chan, Raymond H, et al.
Publicado: (2015)

Prognostic value of late gadolinium enhancement in cardiac MRI of non-ischemic dilated cardiomyopathy patients
por: Behera, Dibya Ranjan, et al.
Publicado: (2020)

Late gadolinium enhancement for re‐worsening left ventricular ejection fraction in patients with dilated cardiomyopathy
por: Nabeta, Takeru, et al.
Publicado: (2020)

Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non‐ischaemic dilated cardiomyopathy
por: Mirelis, Jesús G., et al.
Publicado: (2022)

The Role of Lung Function Testing in Newborn Infants With Congenital Thoracic Arterial Anomalies
por: Columbo, Claudia, et al.
Publicado: (2021)

Evaluation of Drug-Related Receptors in Children With Dilated Cardiomyopathy
por: Guo, Qing, et al.
Publicado: (2019)

Predictive value of electrocardiographic markers in children with dilated cardiomyopathy
por: Wang, Miao, et al.
Publicado: (2022)

Feasibility of the Omaha system for the care of children with dilated cardiomyopathy
por: Zhang, Qin, et al.
Publicado: (2023)

Bio-imaging: late gadolinium enhancement in dilated cardiomyopathy and its relation to novel biomarkers of fibrosis and remodeling
por: Abdel-Aty, Hassan, et al.
Publicado: (2013)

Comparison of Ventricular Inducibility with Late Gadolinium Enhancement and Myocardial Inflammation in Endomyocardial Biopsy in Patients with Dilated Cardiomyopathy
por: Mueller, Karin A. L., et al.
Publicado: (2016)

The Role of Circulating Collagen Turnover Biomarkers and Late Gadolinium Enhancement in Patients with Non-Ischemic Dilated Cardiomyopathy
por: Revnic, Radu, et al.
Publicado: (2022)

Segmental late gadolinium enhancement and gadolinium extracellular volume in hypertrophic cardiomyopathy
por: Levine, Jonathan M, et al.
Publicado: (2016)

Dilated Cardiomyopathy in Pediatric Crohn’s Patient: Is It a Manifestation or Consequence of Therapy?
por: Busaleh, Fadi, et al.
Publicado: (2021)

Late gadolinium enhanced cardiovascular magnetic resonance of lamin A/C gene mutation related dilated cardiomyopathy
por: Holmström, Miia, et al.
Publicado: (2011)

Focal myocardial fibrosis assessed by late gadolinium enhancement cardiovascular magnetic resonance in children and adolescents with dilated cardiomyopathy
por: Latus, Heiner, et al.
Publicado: (2015)

Case series: LMNA‐related dilated cardiomyopathy presents with reginal wall akinesis and transmural late gadolinium enhancement
por: Wang, Shuai, et al.
Publicado: (2020)

Late-Gadolinium Enhancement Interface Area and Electrophysiological Simulations Predict Arrhythmic Events in Patients With Nonischemic Dilated Cardiomyopathy
por: Balaban, Gabriel, et al.
Publicado: (2021)

Blood flow characteristics after aortic valve neocuspidization in paediatric patients: a comparison with the Ross procedure
por: Secinaro, Aurelio, et al.
Publicado: (2021)

Development of Cardiac Events and Functional Recovery Prediction Models for Pediatric Dilated Cardiomyopathy
por: Kim, Dong-Hee, et al.
Publicado: (2021)

Long-Term Outcomes and Prognosticators of Pediatric Primary Dilated Cardiomyopathy in an Asian Cohort
por: Wang, Po-Yuan, et al.
Publicado: (2021)

Non-contrast T1 mapping characterizes the myocardium beyond that achieved by late gadolinium enhancement in both hypertrophic and dilated cardiomyopathy
por: Dass, Sairia, et al.
Publicado: (2012)

Extracellular volume fraction in dilated cardiomyopathy patients without obvious late gadolinium enhancement: comparison with healthy control subjects
por: Im, Dong Jin, et al.
Publicado: (2015)

The study about the difference of extra cellular volume calculated with T1mapping in dilated cardiomyopathy with and without late gadolinium enhancement
por: Teraoka, Kunihiko, et al.
Publicado: (2015)

Overlapping Phenotypes and Degree of Ventricular Dilatation Are Associated with Severity of Systolic Impairment and Late Gadolinium Enhancement in Non-Ischemic Cardiomyopathies
por: Boban, Marko, et al.
Publicado: (2018)

Non-contrast-enhanced T(1) Mapping of Dilated Cardiomyopathy: Comparison between Native T(1) Values and Late Gadolinium Enhancement
por: Yanagisawa, Fumi, et al.
Publicado: (2018)

Correlation between septal midwall late gadolinium enhancement on CMR and conduction delay on ECG in patients with nonischemic dilated cardiomyopathy
por: Becker, Marthe A.J., et al.
Publicado: (2020)

Quantitative analysis of late gadolinium enhancement in hypertrophic cardiomyopathy
por: Aquaro, Giovanni Donato, et al.
Publicado: (2010)

Exuberant Pattern of Late Gadolinium Enhancement in Hypertrophic Cardiomyopathy
por: Fernandes, Elsa, et al.
Publicado: (2013)

Diagnostic and prognostic role of late gadolinium enhancement in cardiomyopathies
por: Aquaro, Giovanni Donato, et al.
Publicado: (2023)

Wilms Tumor with dilated hypertensive cardiomyopathy, acute myocarditis, pulmonary edema, and heart failure
por: Chung, Jae Min, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_olfbdla27ueqb8p877fr75r4jk